Research ArticleClinical Studies
Identifying Melanoma Patients with 1-3 Brain Metastases Who May Benefit from Whole-brain Irradiation in Addition to Radiosurgery
STEFAN HUTTENLOCHER, LENA SEHMISCH, STEVEN E. SCHILD, OLIVER BLANK, DAGMAR HORNUNG and DIRK RADES
Anticancer Research October 2014, 34 (10) 5589-5592;
STEFAN HUTTENLOCHER
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
LENA SEHMISCH
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
STEVEN E. SCHILD
2Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.
OLIVER BLANK
3CyberKnife Centre Northern Germany, Güstrow, Germany
DAGMAR HORNUNG
4Department of Radiation Oncology, University Medical Center Eppendorf, Hamburg, Germany
DIRK RADES
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
In this issue
Anticancer Research
Vol. 34, Issue 10
October 2014
Identifying Melanoma Patients with 1-3 Brain Metastases Who May Benefit from Whole-brain Irradiation in Addition to Radiosurgery
STEFAN HUTTENLOCHER, LENA SEHMISCH, STEVEN E. SCHILD, OLIVER BLANK, DAGMAR HORNUNG, DIRK RADES
Anticancer Research Oct 2014, 34 (10) 5589-5592;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Pre-Treatment Seizures in Patients With 1-3 Cerebral Metastases Receiving Local Therapies Plus Whole-brain Radiotherapy
- Estimating Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Whole-brain Radiotherapy With a New Tool
- A Score to Identify Patients with Brain Metastases from Colorectal Cancer Who May Benefit from Whole-brain Radiotherapy in Addition to Stereotactic Radiosurgery/Radiotherapy
- Predicting the Risk of Developing New Cerebral Lesions After Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastases from Renal Cell Carcinoma
- Validation of a Survival Score for Patients Receiving Radiosurgery or Fractionated Stereotactic Radiotherapy for 1 to 3 Brain Metastases
- Development of a Survival Score for Patients with Cerebral Metastases from Melanoma
- Prognostic Factors After Whole-brain Radiotherapy Alone for Brain Metastases from Malignant Melanoma
- Comparison of 20x2 Gy and 12x3 Gy for Whole-brain Irradiation of Multiple Brain Metastases from Malignant Melanoma
- Predicting the Risk of New Cerebral Lesions After Stereotactic Radiosurgery (SRS) for Brain Metastases from Breast Cancer
- Estimation of the Six-month Survival Probability After Radiosurgery for Brain Metastases from Kidney Cancer